WenyinShiMD

Radiation Oncology • Philadelphia, PA

Benign Diseases, Central Nervous System Cancer, Hematologic Malignancies, Melanoma

Associate Professor, Radiation Oncology, Jefferson Medical College-Thos Jefferson Univ

Join to view full profile

Dr. Shi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shi's full profile

Already have an account?

Office
111 S 11th St
# Bodine
Philadelphia, PA 19107
Phone+1 215-955-6702

Fax+1 215-955-5331

Education & Training

University of FloridaResidency, Radiation Oncology, 2006 - 2010
University of Florida College of MedicineInternship, Transitional Year, 2005 - 2006
Shanghai Medical UniversityClass of 1997

Certifications & Licensure

DE State Medical License Current
PA State Medical License 2010 - 2026
NJ State Medical License 2017 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012

Clinical Trials

Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases Start of enrollment: 2005 Oct 01
Completed
Phase 1
Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases Start of enrollment: 2009 Mar 01
Completed
Phase 1
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies Start of enrollment: 2008 Apr 10
Completed
Phase 2
Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors Start of enrollment: 2012 May 01
Terminated
Phase 1
TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma Start of enrollment: 2007 Oct 01
Completed
High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma Start of enrollment: 2012 Jun 01
Terminated
Phase 1
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies Start of enrollment: 2011 Aug 04
Completed
Phase 2
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer Start of enrollment: 2011 Sep 22
Completed
Phase 1
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2012 Oct 04
Active, not recruiting
Phase 1
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09
Completed
Phase 1
Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy Start of enrollment: 2013 Mar 08
Completed
Not Applicable
Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor Start of enrollment: 2013 Nov 04
Completed
Phase 2
Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
Withdrawn
Phase 1
Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy Start of enrollment: 2013 Nov 11
Completed
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas Start of enrollment: 2015 Jan 30
Completed
Phase 1
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jul 22
Completed
Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma Start of enrollment: 2018 May 04
Completed
Early Phase 1
Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma Start of enrollment: 2019 Aug 09
Completed
Phase 2
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery Start of enrollment: 2017 Feb 21
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma Start of enrollment: 2017 Jul 17
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Body mass index as a prognostic indicator of overall survival in glioblastoma: A systematic review and meta analysis.
Preston Carey, Christopher Gardner, Adam Uppendahl, Jenna Kantor, Louis Cappelli
Journal of Clinical Neuroscience. 2024-12-30
Favorable Outcomes of Patients With High-Risk Uveal Melanoma Treated With a Novel Linear Accelerator-Based Frameless Fractionated Stereotactic Radiosurgery.
Louis Cappelli, Mehak M Khan, Carol L Shields, Sara E Lally, Muhammad Sharif
American Journal of Ophthalmology. 2024-12-18
Machine Learning-based Prognostic Subgrouping of Glioblastoma: A Multi-center Study.
Hamed Akbari, Spyridon Bakas, Chiharu Sako, Anahita Fathi Kazerooni, Javier Villanueva-Meyer
Neuro-Oncology. 2024-12-12

Journal Articles

Multi-Institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients with Brain Metastases
Simon S Lo, Wenyin Shi, Kristin J Redmond, Mitchell Machtay, JAMA Oncology

Authored Content

A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is VirtualJune 2021

Press Mentions

Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 TrialMarch 24th, 2022
Why Is Glioblastoma Such a Tough Nut to Crack?December 24th, 2019
Over 1,000 Multiple Brain Metastases Patients Treated with Brainlab Indication-Specific SoftwareNovember 16th, 2017
Join now to see all